Preparedness for and Prevention of Severe Disease and Sequelae of Respiratory Viruses and Other Respiratory Pathogens
Agency: Centers for Disease Control and Prevention - ERA
Assistance Listings: 93.083 -- Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases
Description
The purpose of this notice of funding opportunity (NOFO) is to support research to prevent and mitigate severe respiratory illness and related complications by studying the epidemiology, prevention, treatment, and outcomes of severe disease and complications of infections with respiratory viruses and other respiratory pathogens. CDC seeks to establish a preparedness and prevention infrastructure to improve public health and clinical outcomes of respiratory illness. Specific NOFO projects may include but are not limited to: 1) a focus on immunity and protection of people at high-risk, including pregnant women and infants, children, older adults, and people with immunocompromising and other high-risk conditions; 2) detection and prevention of respiratory pathogens including respiratory viruses (e.g., respiratory syncytial virus [RSV], human metapneumovirus [hMPV]) and other respiratory pathogens (e.g., pertussis, mycoplasma pneumoniae); 3) evaluation of effectiveness of prevention products including vaccines and monoclonal antibodies against disease; 4) assessment of uptake and use of treatment products including antiviral drugs, antimicrobials, and immunomodulators; 5) description of sequelae and outcomes related to respiratory illness up to 2 years after infection, such as diagnoses of recurrent wheezing and asthma, developmental delays, other post-infection symptoms and diagnoses, subsequent respiratory infections (e.g., otitis media, invasive pneumococcal disease, etc.), and antibiotic use; 6) study of economic impacts of respiratory disease and prevention products; and 7) establishment of response infrastructure in preparation for public health emergencies related to respiratory illnesses. Study activities may involve creating specific cohorts and using interviews, medical record reviews, and sample collection and testing. Researchers may also obtain data from large administrative electronic health record (EHR) databases using linked maternal and infant records, laboratory results, vaccine/immunization records, and data from inpatient and outpatient encounters to address relevant questions.
Eligibility
Eligible applicants
Government
- Federally recognized Native American tribal governments
- County governments
- State governments
- Special district governments
- City or township governments
- Public and Indian housing authorities
Education
- Private institutions of higher education
- Public and state institutions of higher education
- Independent school districts
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
Business
- For-profit organizations other than small businesses
Additional information
Grantor contact information
Description
AYang@cdc.gov
Documents
No documents are currently available.
Link to additional information
--
Forecasted
Estimated Post Date:
December 31, 2025
Estimated Application Due Date:
March 1, 2026
Estimated Due Date Description:
Not available
Estimated Award Date:
August 15, 2026
Estimated Project Start Date:
September 1, 2026
Fiscal Year:
2026
Award
$50,000,000
Program Funding
5
Expected awards
$1,500,000
Award Minimum
$2,000,000
Award Maximum
Funding opportunity number:
RFA-IP-26-100
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Health
Category Explanation:
History
Version:
1
Forecast posted date:
August 1, 2025
Archive date:
March 31, 2026
